BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 37191192)

  • 1. Dentoalveolar Alterations in an Adenine-Induced Chronic Kidney Disease Mouse Model.
    Mohamed FF; Amadeu de Oliveira F; Kinoshita Y; Yalamanchili RR; Eltilib LA; Andras NL; Narisawa S; Tani T; Chu EY; Millán JL; Foster BL
    J Bone Miner Res; 2023 Aug; 38(8):1192-1207. PubMed ID: 37191192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease.
    Tani T; Orimo H; Shimizu A; Tsuruoka S
    Sci Rep; 2017 May; 7(1):2233. PubMed ID: 28533541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model.
    Tani T; Fujiwara M; Orimo H; Shimizu A; Narisawa S; Pinkerton AB; Millán JL; Tsuruoka S
    J Pathol; 2020 Jan; 250(1):30-41. PubMed ID: 31509234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased PHOSPHO1 expression mediates cortical bone mineral density in renal osteodystrophy.
    Hsu SN; Stephen LA; Dillon S; Milne E; Javaheri B; Pitsillides AA; Novak A; Millán JL; MacRae VE; Staines KA; Farquharson C
    J Endocrinol; 2022 Sep; 254(3):153-167. PubMed ID: 35900032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of increased osteopontin and hypophosphatemia to dentoalveolar defects in osteomalacic Hyp mice.
    Mohamed FF; Hoac B; Phanrungsuwan A; Tan MH; Giovani PA; Ghiba S; Murshed M; Foster BL; McKee MD
    Bone; 2023 Nov; 176():116886. PubMed ID: 37634682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dentoalveolar Defects in the
    Zhang H; Chavez MB; Kolli TN; Tan MH; Fong H; Chu EY; Li Y; Ren X; Watanabe K; Kim DG; Foster BL
    J Dent Res; 2020 Apr; 99(4):419-428. PubMed ID: 31977267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
    Cejka D; Wakolbinger-Habel R; Zitt E; Fahrleitner-Pammer A; Amrein K; Dimai HP; Muschitz C
    Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dentoalveolar Defects of Hypophosphatasia are Recapitulated in a Sheep Knock-In Model.
    Mohamed FF; Chavez MB; Huggins S; Bertels J; Falck A; Suva LJ; Foster BL; Gaddy D
    J Bone Miner Res; 2022 Oct; 37(10):2005-2017. PubMed ID: 36053890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.
    Sugatani T; Agapova OA; Fang Y; Berman AG; Wallace JM; Malluche HH; Faugere MC; Smith W; Sung V; Hruska KA
    Kidney Int; 2017 Jan; 91(1):86-95. PubMed ID: 27666759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease.
    Lau WL; Linnes M; Chu EY; Foster BL; Bartley BA; Somerman MJ; Giachelli CM
    Nephrol Dial Transplant; 2013 Jan; 28(1):62-9. PubMed ID: 23045434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of Osteoblast PKC Signaling Reduces Cortical Bone Mass and Density and Aggravates Renal Osteodystrophy in Mice with Chronic Kidney Disease on High Phosphate Diet.
    Zaloszyc A; Choquet P; Sayeh A; Bartosova M; Schaefer B; Huegel U; Aubertin-Kirch G; Healy C; Severac F; Rizzo S; Boivin G; Schaefer F; Fischbach M; Bacchetta J; Bahram S; Schmitt CP
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
    Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular, valvular and kidney calcification manifested in mouse models of adenine-induced chronic kidney disease.
    Yang X; Liu Y; Zhu X; Chen P; Xie X; Xu T; Zhang X; Zhao Y
    Ren Fail; 2023 Dec; 45(1):2228920. PubMed ID: 37369635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet.
    Ni LH; Tang RN; Lv LL; Wu M; Wang B; Wang FM; Ni HF; Song KY; Wang LT; Meng-Zuo ; Chen Q; Liu BC
    Biochem Biophys Res Commun; 2018 Apr; 498(3):654-659. PubMed ID: 29545182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Therapy Using Adeno-Associated Virus Serotype 8 Encoding TNAP-D
    Kinoshita Y; Mohamed FF; Amadeu de Oliveira F; Narisawa S; Miyake K; Foster BL; Millán JL
    J Bone Miner Res; 2021 Sep; 36(9):1835-1849. PubMed ID: 34076297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.
    Mathew S; Davies M; Lund R; Saab G; Hruska KA
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():43-50. PubMed ID: 16884397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin Protects Against Vascular Calcification Development in Mice.
    De Maré A; Opdebeeck B; Neven E; D'Haese PC; Verhulst A
    J Bone Miner Res; 2022 Apr; 37(4):687-699. PubMed ID: 35038187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional Alpl Ablation Phenocopies Dental Defects of Hypophosphatasia.
    Foster BL; Kuss P; Yadav MC; Kolli TN; Narisawa S; Lukashova L; Cory E; Sah RL; Somerman MJ; Millán JL
    J Dent Res; 2017 Jan; 96(1):81-91. PubMed ID: 27582029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.